Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.

Abstract:

BACKGROUND/AIM:Salvage androgen-deprivation therapy (ADT) is standard treatment for recurrent prostate cancer after curative therapy. However, the prognostic impact of different treatment modalities on the time to castration resistance remains unclear. In this study, we investigated the prognosis of men treated with salvage ADT after initial radical prostatectomy or radiotherapy for prostate cancer. PATIENTS AND METHODS:Between 2000 and 2013, 149 Japanese men with recurrent prostate cancer who were initially treated with radical prostatectomy (n=95) or radiotherapy (n=54) and were subsequently treated with salvage ADT after disease recurrence were enrolled in this study. The prognostic significance of the curative treatment modality and clinicopathological findings were analyzed. RESULTS:During a median follow-up period of 4.7 years after recurrence, castration-resistant progression was observed in 22 men. The 5-year progression-free survival, metastasis-free survival, cause-specific survival, and overall survival rates for all patients were 86.3%, 81.4%, 95.7%, and 94.5%, respectively. Multivariate analysis identified the biopsy Gleason score at initial diagnosis and the initial curative treatment modality as significant predictors of castration resistance. CONCLUSION:This study showed that low biopsy Gleason score (≤7) at diagnosis and radical prostatectomy as the curative treatment may be favorable prognostic factors for treatment with salvage ADT.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Obata H,Shiota M,Akitake N,Takeuchi A,Kashiwagi E,Dejima T,Kiyoshima K,Inokuchi J,Tatsugami K,Eto M

doi

10.21873/anticanres.11998

subject

Has Abstract

pub_date

2017-10-01 00:00:00

pages

5631-5637

issue

10

eissn

0250-7005

issn

1791-7530

pii

37/10/5631

journal_volume

37

pub_type

杂志文章
  • Inhibitory effect of deferoxamine mesylate and low iron diet on the 13762NF rat mammary adenocarcinoma.

    abstract::The iron chelator deferoxamine mesylate has been shown to inhibit the growth of a variety of human malignant cell lines and the rat 13762NF mammary adenocarcinoma cell line. In vivo studies in mice have also demonstrated that an iron deficiency induced by either feeding a low iron diet or injecting the iron chelator d...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Wang F,Elliott RL,Head JF

    更新日期:1999-01-01 00:00:00

  • Antisense p53 oligonucleotides inhibit proliferation and induce chemosensitivity in follicular thyroid cancer cells.

    abstract:BACKGROUND:The potential of MTp53 knockout by oligodesoxyribonucleotide phosphothioates (ODNs) to affect proliferation, apoptosis and chemosensitivity in undifferentiated thyroid cancer (UTC) cells with a recessive MTp53 mutation was evaluated. MATERIALS AND METHODS:Transient transfections with ODNs complementary to p...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hassan I,Wunderlich A,Burchert A,Hoffmann S,Zielke A

    更新日期:2006-03-01 00:00:00

  • Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer.

    abstract::The attempts to identify, isolate and characterize cancer stem cell populations are mostly dependent on cell-surface markers. In breast cancer, several putative breast cancer stem cell (BCSC) markers have already been reported, but the agreement on their phenotypic characterization is still absent. In fact, it became ...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:10.21873/anticanres.11552

    authors: DA Cruz Paula A,Lopes C

    更新日期:2017-05-01 00:00:00

  • Induction of apoptosis in glioblastoma cells by an atypical protein kinase C pseudosubstrate peptide.

    abstract:BACKGROUND:Glioblastoma responds poorly to standard chemotherapy agents. The expression of a mutant, constitutively-active EGF receptor (EGFRvIII) is common in glioblastoma and contributes to chemotherapy resistance. We have assessed the cytotoxicity of an inhibitor of atypical protein kinase C on glioblastoma cells ex...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lorimer IA,Parolin DA,Lavictoire SJ

    更新日期:2002-03-01 00:00:00

  • Colorectal Kaposi's sarcoma in an HIV-negative male in association with ulcerative rectocolitis: a case report.

    abstract::A rare case and the first reported in Italy of a classic form of colorectal Kaposi's sarcoma, associated with ulcerative rectocolitis, is presented. Following a total proctocolectomy, the patient was disease-free at four years. Some epidemiological risk factors such as sex, age, place of birth and both advanced malari...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Tedesco M,Benevolo M,Frezza F,Mancini R,Carone MD,Mottolese M,Cosimelli M

    更新日期:1999-07-01 00:00:00

  • Dynamics of Circulating Tumor Cells Early After Targeting Therapy to Human EGFR-mutated Lung Cancers and HER2 Gene-amplified Gastric Cancers in Mice.

    abstract:BACKGROUND/AIM:Dynamics of circulating tumor cells (CTCs) after molecular targeting therapy remain unclear. MATERIALS AND METHODS:We examined changes in CTC numbers and morphology early after targeting therapy in EGFR-mutated PC-9 human lung cancer and HER2-gene amplified GLM-1 gastric cancer mouse CTC models using a ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13653

    authors: Ito A,Nakanishi H,Yoshimura M,Ito S,Sakao Y,Kodera Y,Yatabe Y,Kaneda N

    更新日期:2019-09-01 00:00:00

  • In vitro and in vivo interactions of D-penicillamine with tumors.

    abstract::D-penicillamine (PSH) is a copper chelator that generates hydrogen peroxide and inhibits neovascularization. As hydrogen peroxide is toxic to some tumor cells and to blood vessels, we reasoned that PSH plus copper would inhibit tumors in vivo and in vitro. To test this hypothesis, we first incubated murine J558L plasm...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Samoszuk M,Nguyen V

    更新日期:1996-05-01 00:00:00

  • DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.

    abstract::The identification of new prognostic parameters in Superficial Transitional Cell Carcinoma of the Bladder (STCCB) is important since conventional methods are often insufficient for prognostic purposes. We studied the proliferation activity and the DNA ploidy status of 60 pTa and pT1 Superficial Transitional Cell Carci...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pantazopoulos D,Ioakim-Liossi A,Karakitsos P,Aroni K,Kakoliris S,Kanavaros P,Kyrkou KA

    更新日期:1997-01-01 00:00:00

  • Synergistic effects of adriamycin and TALL-104 cell therapy against a human gastric carcinoma in vivo.

    abstract::The single and combined antitumor effects of adriamycin and a major histocompatibility complex non-restricted human cytotoxic T cell line (TALL-104) were evaluated in severe combined immunodeficient (SCID) mice engrafted subcutaneously with a biopsy sample from a patient with a highly metastatic gastric carcinoma. Che...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Cesano A,Visonneau S,Rovera G,Santoli D

    更新日期:1997-05-01 00:00:00

  • Primary neuroendocrine carcinoma of the appendix: a case report and review of the literature.

    abstract:AIM:We report on a rare case of appendiceal primary neuroendocrine carcinoma (NEC) and discuss three cases previously described. CASE REPORT:A 58-year-old woman presented with acute abdominal pain and a low-grade fever. She was diagnosed with acute appendicitis and underwent laparoscopic appendectomy. Pathological exa...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Tomioka K,Fukoe Y,Lee Y,Lee M,Wada Y,Aoki T,Murakami M

    更新日期:2013-06-01 00:00:00

  • Endothelium-specific expression of an E-selectin promoter recombinant adenoviral vector.

    abstract:BACKGROUND:E-selectin expression is very low in normal adult blood vessels, but is significantly elevated in newly formed tumor capillaries. We hypothesized that a viral vector which has transcriptional specificity for the tumor vasculature may be a tool for angiogenesis-targeted gene therapy. We therefore designed an ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Walton T,Wang JL,Ribas A,Barsky SH,Economou J,Nguyen M

    更新日期:1998-05-01 00:00:00

  • Detection of treated liver metastases using fluorine-18-fluordeoxyglucose (FDG) and positron emission tomography (PET).

    abstract::The aim of the study was the evaluation of the detectability of treated liver metastases using one FDG-PET measurement. The study includes 42 patients (80 lesions) from different primary tumours. Standardized Uptake Values (SUV) as well as the tumour to liver Ratio (T/L) were used for evaluation. A T/L > 1.0 was consi...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Mantaka P,Strauss AD,Strauss LG,Moehler M,Goldschmidt H,Oberdorfer F,Kontaxakis G,Van Kaick G

    更新日期:1999-09-01 00:00:00

  • The RING finger protein11 binds to Smad4 and enhances Smad4-dependant TGF-beta signalling.

    abstract:BACKGROUND:In breast carcinomas, prolonged signalling through the TGF-beta receptor promotes latent tumour progression, metastasis and the epithelial-to-mesenchymal transition of tumour cells. Previously, it has been found that the 154 amino acid RING finger protein, RNF11, was overexpressed in high-grade breast tumour...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Azmi PB,Seth AK

    更新日期:2009-06-01 00:00:00

  • Immunization with TGF-beta antisense oligonucleotide-modified autologous tumor vaccine enhances the antitumor immunity of MBT-2 tumor-bearing mice through upregulation of MHC class I and Fas expressions.

    abstract::The major purpose of this study was to define if the immunosuppressive effect of a transforming growth factor-beta (TGF-beta)-producing autologous tumor vaccine can be abrogated and rendered immunogenic by suppressing its TGF-beta secretion with antisense strategy. In this study, using a TGF-beta antisense gene modifi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tzai TS,Shiau AL,Liu LL,Wu CL

    更新日期:2000-05-01 00:00:00

  • Up-regulation of glypican-3 in human hepatocellular carcinoma.

    abstract:AIM:To investigate the expression and significance of glypican-3 (GPC3) in human hepatocellular carcinoma (HCC). MATERIALS AND METHODS:DNA chips were used to measure the expression of mRNAs for members of the glypican and syndecan families of heparan sulfate proteoglycans (HSPGs) in normal liver tissue, non-tumor tiss...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Suzuki M,Sugimoto K,Tanaka J,Tameda M,Inagaki Y,Kusagawa S,Nojiri K,Beppu T,Yoneda K,Yamamoto N,Ito M,Yoneda M,Uchida K,Takase K,Shiraki K

    更新日期:2010-12-01 00:00:00

  • Effect of Eudragit on In Vitro Transfection Efficiency of PEI-DNA Complexes.

    abstract:AIM:Eudragit® E 100 (EE100) was used to improve the transfection efficiency of polyethylenimine (PEI). MATERIALS AND METHODS:Mobility of PEI-DNA complexes with and without EE100 were visualized by agarose gel electrophoresis and their transfection efficiencies were investigated in KB human oral carcinoma cells by flow...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kanthamneni N,Yung B,Lee RJ

    更新日期:2016-01-01 00:00:00

  • Adjuvant interferon alpha therapy in renal cell carcinoma (RCC): prognostic value of DNA cytophotometry.

    abstract:BACKGROUND:Adjuvant immunotherapy with interferon alpha in non-metastatic RCC is still controversial. It was the aim of the present study to investigate whether tumor ploidy can help to isolate a group of patients profitting from this treatment. MATERIALS AND METHODS:Survival data of 119 patients undergoing tumor neph...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Basting R,Corvin S,Händel D,Hinke A,Schmidt D

    更新日期:1999-03-01 00:00:00

  • MicroRNA-203 Induces Apoptosis by Targeting Bmi-1 in YD-38 Oral Cancer Cells.

    abstract:BACKGROUND/AIM:MicroRNAs (miRNAs) are closely associated with a number of cellular processes, including cell development, differentiation, proliferation, carcinogenesis, and apoptosis. The aim of the present study was to elucidate the molecular mechanisms underlying the tumor suppressor activity of miRNA-203 (miR-203) ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12618

    authors: Kim JS,Choi DW,Kim CS,Yu SK,Kim HJ,Go DS,Lee SA,Moon SM,Kim SG,Chun HS,Kim J,Kim JK,Kim DK

    更新日期:2018-06-01 00:00:00

  • Antitumor metallocenes: new developments and toxicologic features.

    abstract::Recent results concerning new antitumor metallocene derivatives have shown that not only numerous titanocene dihalides and bis(pseudohalides) exhibit antiproliferative activity, but that also some titanocene complexes (C5H5)2TiX2 containing carboxylates or hydrochlorinated aminothiophenolates as ligands X, are charact...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Köpf-Maier P,Köpf H

    更新日期:1986-03-01 00:00:00

  • The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice.

    abstract::We have previously shown that oral administration of PSK not only exerts antitumor activity, but also restores immune response in tumor-bearing mice. In order to analyze the immunomodulative effect of PSK, we investigated the effects of oral PSK on the intestinal immune systems in ICR mice bearing sarcoma 180. Oral ad...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Matsunaga K,Morita I,Oguchi Y,Fujii T,Yoshikumi C,Nomoto K

    更新日期:1987-05-01 00:00:00

  • Serum testosterone: A potentially adjunct screening test for the assessment of the risk of prostate cancer among men with modestly elevated PSA values (> or =3.0 and

    abstract::Whether serum testosterone (T) can become an adjunct test able to validate the PSA-weighted risk of prostate cancer (PR.CA) in the "grey" diagnostic area (PSA =3.0 to <10.0 ng/ml) was investigated. Seven hundred and eighteen men participated in a prostate screening program using the cutoff PSA value of > or =3.0 ng/ml...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Karamanolakis D,Lambou T,Bogdanos J,Milathianakis C,Sourla A,Lembessis P,Halapas A,Pissimissis N,Dessypris N,Petridou ET,Koutsilieris M

    更新日期:2006-07-01 00:00:00

  • Immunomodulation activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines.

    abstract::Some non-differentiation-induction benzo[a]phenothiazines and mutagenic benz[c]acridines more potently inhibited the mitogen-induced blast transformation of human-peripheral blood lymphocytes than differentiation-induction and non-mutagenic counterparts and phenothiazines. Differential absorption spectrophotometry rev...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Molnar J,Mandi Y,Petri I,Petofi S,Sakagami H,Kurihara T,Motohashi N

    更新日期:1993-03-01 00:00:00

  • Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma.

    abstract:AIM:To evaluate (18)F-fluorodihydroxyphenylalanine-positron emission tomography/ contrast-enhanced computed tomography ((18)F-DOPA PET/CT) for the detection of paragangliomas (PARA) without any patient selection, such as genetic predisposition for the development of these tumors, history of metastatic PARA or hormonal ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: El-Rabadi K,Weber M,Mayerhofer M,Nakuz T,Scherer T,Mitterhauser M,Dudczak R,Hacker M,Karanikas G

    更新日期:2016-08-01 00:00:00

  • Clinical randomized study of 5FU monitoring versus standard dose in patients with head and neck cancer: preliminary results.

    abstract::Prospective studies of dose adaptation of continuous 5FU infusion combined with cisplatin have shown that pharmacologically guided dosing was feasible in the treatment of head and neck carcinomas. Adaptative dosing results in reduced haematological toxicity, but few data are available for clinical response rate. Preli...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Fety R,Rolland F,Barberi-Heyob M,Merlin JL,Conroy T,Hardouin A,Riviere A,Milano G

    更新日期:1994-11-01 00:00:00

  • Carcinoma of the axillary tail of Spence: a case series.

    abstract::There is sparse information about cancer in the axillary tail of Spence (CATS). Eight hundred and thirty-nine patients with breast cancer were retrospectively studied for the occurrence of CATS. Ten patients were identified based on detection by imaging studies. A tendency towards stage II or III disease, and estrogen...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ampil F,Caldito G,Henderson B,Li B,Kim RH,Burton G,Chu Q

    更新日期:2012-09-01 00:00:00

  • Elective Nodal Irradiation for Non-small Cell Lung Cancer Complicated With Chronic Obstructive Pulmonary Disease Affects Immunotherapy Αfter Definitive Chemoradiotherapy.

    abstract:BACKGROUND/AIM:The aim of this retrospective study was to detect the frequency, reasons, and significant factors for not receiving immunotherapy after chemoradiotherapy in non-small cell lung cancer (NSCLC) patients. PATIENTS AND METHODS:Thirty-four patients with NSCLC received definitive chemoradiotherapy. The endpoi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14720

    authors: Morimoto M,Nishino K,Wada K,Imamura F,Konishi K,Kuhara H,Tamiya M,Inoue T,Kunimasa K,Kimura M,Hirata T,Kanayama N,Toratani M,Kawachi H,Ohira K,Nakanishi E,Ohira S,Sagawa T,Miyazaki M,Matsunaga T,Kumagai T,Teshim

    更新日期:2020-12-01 00:00:00

  • Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.

    abstract:BACKGROUND:The role of combination chemotherapy regimens in the management of ovarian cancer patients with tumors previously exposed to platinum compounds and paclitaxel has not yet been defined. The present phase II study evaluated the activity and toxicity of a paclitaxel-ifosfamide-cisplatin combination in the afore...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Polyzos A,Kosmas C,Tsavaris N,Toufexi H,Lagadas A,Gogas H,Giannakopoulos K,Kouraklis G,Griniatsos J,Felekouras E,Tsigris C,Nikiteas N,Papadopoulos O,Giannopoulos A

    更新日期:2007-05-01 00:00:00

  • Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.

    abstract:AIMS:(a) To assess the expression patterns of HER2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive ductal cancer (IDC) and IDC associated with carcinoma in situ (IDC/DCIS) and (b) to determine if there is a differential expression of these molecular markers between IDC and IDC/DCIS. MATERIALS AND METHODS:...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Mylonas I,Makovitzky J,Jeschke U,Briese V,Friese K,Gerber B

    更新日期:2005-05-01 00:00:00

  • Potent Antitumor T-Cell Memory Is Generated by Curative Viral Oncolytic Immunotherapy But Not Curative Chemotherapy.

    abstract:BACKGROUND:Late developing breast cancer metastases are common and lethal despite treatment with adjuvant chemotherapy at the time of primary tumor excision. Stimulation of an antitumor immune response is an alternative strategy for preventing this devastating development. MATERIALS AND METHODS:A mouse model of the hu...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13029

    authors: Gao Y,Bergman I

    更新日期:2018-12-01 00:00:00

  • Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination.

    abstract:BACKGROUND:Medullary thyroid carcinoma (MTC) is a calcitonin-producing tumor of the parafollicular C-cells, accounting for 5-10% of all thyroid tumors. To date, the only effective treatment is the early and total surgical removal of all neoplastic tissue. As the prognosis of patients with advanced MTC, unresectable or ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Pfragner R,Skofitsch G,Höger H,Jech M,Rinner B,Siegl V,Niederle B,Gnant M,Friedl J,Stift A

    更新日期:2005-11-01 00:00:00